Cas:1094322-91-4 1-[2-(4-Morpholinyl)ethoxy] manufacturer & supplier

Chemical Name:1-[2-(4-Morpholinyl)ethoxy]

CAS.NO:1094322-91-4

Synonyms:2-morpholin-4-ylethyl (E)-6-[4-hydroxy-6-methoxy-7-methyl-1-(2-morpholin-4-ylethoxy)-3-oxo-1H-2-benzofuran-5-yl]-4-methylhex-4-enoate;Mycophenolate Mofetil Impurity 2

Molecular Formula:C₂₉H₄₂N₂O₉

Molecular Weight:562.65200

HS Code:

Physical and Chemical Properties:

Melting point:N/A

Boiling point:N/A

Density:N/A

Index of Refraction:

PSA:116.23000

Exact Mass:562.28900

LogP:2.24720

Material Safety Information (Applicable for Hazard Chemicals)

RIDADR:

Packing Group:

Contact us for information like 2-morpholin-4-ylethyl (E)-6-[4-hydroxy-6-methoxy-7-methyl-1-(2-morpholin-4-ylethoxy)-3-oxo-1H-2-benzofuran-5-yl]-4-methylhex-4-enoate chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,Mycophenolate Mofetil Impurity 2 physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,Mycophenolate Mofetil Impurity 2 Use and application,Mycophenolate Mofetil Impurity 2 technical grade,usp/ep/jp grade.

Related News: The foundational patent, which expires in 2034, is owned by MSK and is licensed exclusively to Fate Therapeutics for all human therapeutic uses. 1-[2-(4-Morpholinyl)ethoxy] manufacturer The foundational patent, which expires in 2034, is owned by MSK and is licensed exclusively to Fate Therapeutics for all human therapeutic uses. 1-[2-(4-Morpholinyl)ethoxy] supplier It does not require a production license for the drug substance, and can be produced in an ordinary chemical plant. As long as it reaches a certain level, it can be used for the synthesis of the drug substance. 1-[2-(4-Morpholinyl)ethoxy] vendor Many domestic raw material pharmaceutical and intermediate manufacturing companies with strong capital and talent reserves and advanced technology and processes have developed in the country, and the competitiveness of market participants has continued to increase. 1-[2-(4-Morpholinyl)ethoxy] factory China’s pharmaceutical CMO market has recently maintained a growth rate of more than 10%. From the perspective of market structure, the average growth rate of clinical production is 9.5%, while the average growth rate of commercial production will reach 18.7%.